Mutations in the X region and core promo
β
Charles Hannoun; Peter Horal; Kim Krogsgaard; Magnus Lindh
π
Article
π
2001
π
John Wiley and Sons
π
English
β 204 KB
## Abstract Therapy for chronic hepatitis B with interferonβΞ± (IFN) may result in viral clearance and hepatitis B e seroconversion in 30β40% of patients. It is still unclear whether viral genetic variability influences response rates. However, certain core promoter mutations were recently associate